HilleVax
HLVX
HLVX was delisted on the 16th of September, 2025.
79 hedge funds and large institutions have $73.5M invested in HilleVax in 2024 Q3 according to their latest regulatory filings, with 22 funds opening new positions, 27 increasing their positions, 18 reducing their positions, and 37 closing their positions.
50% more repeat investments, than reductions
Existing positions increased: 27 | Existing positions reduced: 18
7.68% less ownership
Funds ownership: 91.52% → 83.85% (-7.7%)
16% less funds holding
Funds holding: 94 → 79 (-15)
41% less first-time investments, than exits
New positions opened: 22 | Existing positions closed: 37
50% less funds holding in top 10
Funds holding in top 10: 6 → 3 (-3)
89% less capital invested
Capital invested by funds: $658M → $73.5M (-$584M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TCM
Tang Capital Management
San Diego,
California
|
+$12.6M |
| 2 |
B
Braidwell
Stamford,
Connecticut
|
+$2.73M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
+$2.6M |
| 4 |
Acadian Asset Management
Boston,
Massachusetts
|
+$1.44M |
| 5 |
TC
Trium Capital
London,
United Kingdom
|
+$1.16M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
T. Rowe Price Investment Management
Baltimore,
Maryland
|
-$50.3M |
| 2 |
DTC
Deep Track Capital
Greenwich,
Connecticut
|
-$26.5M |
| 3 |
Janus Henderson Group
London,
|
-$16.1M |
| 4 |
MB
MPM BioImpact
Boston,
Massachusetts
|
-$9.33M |
| 5 |
Point72 Asset Management
Stamford,
Connecticut
|
-$6.96M |
HLVX Hedge Fund Activity: Q3 2024 in Review
79 of the 6,979 institutional investors tracked by Wall St. Rank reported a position in HilleVax (HLVX) for Q3 2024, worth a combined $73.5M — down 89% from $658M a quarter earlier.
Sellers outnumbered buyers: 37 funds closed out of HLVX and 22 opened new positions — a net loss of 15 holders — while 18 trimmed existing stakes and 27 added.
The largest buyer was Tang Capital Management, opening a new position worth an estimated $12.6M. The largest seller was T. Rowe Price Investment Management, exiting entirely with an estimated $50.3M sold.
- 79 institutional investors held HilleVax (HLVX) as of Q3 2024, down from 94 in Q2 2024.
- Funds reported $73.5M of HilleVax stock for Q3 2024, down 89% quarter-over-quarter.
- 22 funds opened new HilleVax positions in Q3 2024 and 37 closed out, a net change of -15 holders.
- The largest HilleVax buyer in Q3 2024 was Tang Capital Management, an estimated $12.6M added.
- The largest HilleVax seller in Q3 2024 was T. Rowe Price Investment Management, an estimated $50.3M sold.
Based on aggregated 13F filings for Q3 2024.